133 related articles for article (PubMed ID: 21545624)
21. Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient.
Wils V; Golüke-Willemse G
Int J Geriatr Psychiatry; 1997 Feb; 12(2):272. PubMed ID: 9097225
[No Abstract] [Full Text] [Related]
22. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
23. Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.
Atmaca M; Ozdemir H; Cetinkaya S; Parmaksiz S; Belli H; Poyraz AK; Tezcan E; Ogur E
J Psychiatr Res; 2007 Nov; 41(10):821-7. PubMed ID: 16950400
[TBL] [Abstract][Full Text] [Related]
24. Peripheral oedema in quetiapine therapy.
McSkimming AJ; Dham P; Alexander J; Dinesh A
Aust N Z J Psychiatry; 2012 Aug; 46(8):790-1. PubMed ID: 22848062
[No Abstract] [Full Text] [Related]
25. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.
Atmaca M; Yildirim H; Ozdemir H; Ogur E; Tezcan E
Psychol Med; 2007 Jan; 37(1):121-9. PubMed ID: 17094813
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.
Delbello MP; Schwiers ML; Rosenberg HL; Strakowski SM
J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1216-23. PubMed ID: 12364843
[TBL] [Abstract][Full Text] [Related]
30. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
Suppes T; Vieta E; Gustafsson U; Ekholm B
Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
[TBL] [Abstract][Full Text] [Related]
31. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.
Bakken GV; Rudberg I; Molden E; Refsum H; Hermann M
Ther Drug Monit; 2011 Apr; 33(2):222-6. PubMed ID: 21383647
[TBL] [Abstract][Full Text] [Related]
33. Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine.
Chou YC; Chao FH; Chou YH
J Formos Med Assoc; 2014 Mar; 113(3):195-6. PubMed ID: 24630038
[No Abstract] [Full Text] [Related]
34. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
35. [Cognitive impairment and parkinsonism due to use of sodium valproate].
Schreur L; Middeljans-Tijssen CW; Hengstman GJ; Olde Rikkert MG
Tijdschr Gerontol Geriatr; 2009 Feb; 40(1):29-33. PubMed ID: 19326700
[TBL] [Abstract][Full Text] [Related]
36. [A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
Ricard C; Martin K; Tournier M; Bégaud B; Verdoux H
Encephale; 2005; 31(1 Pt 1):98-101. PubMed ID: 15971646
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic evidence for manic episode].
Terao T
Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
[TBL] [Abstract][Full Text] [Related]
38. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder.
Vieta E; Suppes T; Ekholm B; Udd M; Gustafsson U
J Affect Disord; 2012 Dec; 142(1-3):36-44. PubMed ID: 23062763
[TBL] [Abstract][Full Text] [Related]
40. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
